AMNEAL PHARMACEUTICALS, INC. (AMRX) Net income 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$72.1MFY2025 · since FY2016: $0 → $72.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $72.1M | +161.6% |
| FY2024 | -$116.9M | -39.2% |
| FY2023 | -$84.0M | +69.0% |
| FY2022 | -$270.6M | -2155.6% |
| FY2021 | $13.2M | -80.6% |
| FY2020 | $67.8M | +111.2% |
| FY2019 | -$603.6M | -2957.0% |
| FY2018 | -$19.7M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice